What's New :
Open Session for INTEGRATED PREPARATION for Prelims and Mains. Register Now

WHO moves to roll out first malaria vaccine in Africa

  • Category
    International Relations
  • Published
    29th Jul, 2022


World Health Organization announced the rollout of the world's first authorized malaria vaccine in three African countries


About the Vaccine

  • The WHO recommendation is for RTS, S - or Mosquirix- a vaccine developed by British drug maker GlaxoSmithKline.
  • The active ingredient in Mosquirix is made up of proteins found on the surface of Plasmodium falciparum parasites (PFP).
  • RTS, S aims to start the immune system in the early stages of malaria when PFP enters the bloodstream through a mosquito bite and infects liver cells.
  • The RTS malaria vaccine, S / AS01 is used to prevent falciparum malariain children living in regions with moderate to high transmission.
    • Falciparum, the most common form of malaria in Africa.
  • It is the first vaccine and the only one that shows partial protection against young children.
  • The malaria vaccine should be given in a 4-dose program to children from five months of age to reduce the incidence of malaria and the burden.
  • The vaccine adds to the development of the malaria tool and can help get malaria control back on track.
  • It also helps prevent liver infection with the Hepatitis B virus.


  • Malaria is a life-threatening disease caused by parasites transmitted to humans through the bite of female Anopheles mosquitoes.
  • It is preventable and curable.
  • Over the past two decades, 11 countries have been WHO-certified free of malaria:
    • United Arab Emirates (2007)
    • Morocco (2010)
    • Turkmenistan (2010)
    • Armenia (2011)
    • Sri Lanka (2016)
    • Kyrgyzstan (2016)
    • Paraguay (2018)
    • Uzbekistan (2018)
    • Algeria (2019)
    • Argentina (2019)
    • El Salvador (2021)

Verifying, please be patient.

Enquire Now